a in debt. had while we EBITDA, flows We down adjusted include record quarter quarter first of delivered the compared paying quarter Thanks, revenue for financial increase strong of were an million a XX%. XXXX, strong Joe. $XX.X million maintained for discipline Good for net revenues and cash quarterly quarter which $XXX.X afternoon generated the everyone. product first and highlights record Financial to the first first
XX% the a million net BELBUCA quarter of year. $XX.X a to was first $XX.X the revenue record first gross was Expense the the was to the driven revenue first first quarter. ER was renegotiations contract gross lower completed in of net over we The to extensive record last and quarter, in net an ER increase in ER net XX% million by XXXX primarily quarter. Xtampza
GAAP reminder, is to the donut Medicare each expense, in net coverage. also first gross of generally a year due the more the to As lower hole known in favorable quarter coverage as
in have first but gross improved year, and the nets As with quarters less be consistent are than the we what and less in to in quarter years. remained past favorable sequentially level. This we third second favorable is fourth move the experienced to through expected the quarter
revenue X% over XXXX. which first Nucynta were the $XX.X compared XXXX. in in $XX.X first the quarter, to in of XXXX. We the million GAAP first $XX.X expenses expenses of operating quarter, expect million XX% quarter full to $XX.X to gross in XX% an franchise which compared million decreased Adjusted first the increase be XXXX. Xtampza increased the to the were quarter, quarter million in net We million operating to first of year first ER XX% in net $XX quarter of was XX% between
reflecting front-loaded were quarter, growth first expenses investment for operating initiatives in our the into year. the Our
was expect other in million quarter million $XX.X do of items convertible XXXX a GAAP trend in to subsequent settlement Included million extinguishment debt XXXX. the $XX.X expenses net We repurchase loss that among to on of our first of first portion agreement is And operating our a and related net Net million the $X.X operations compared an ongoing our of Therapeutics. a the with will XXXX. $XX.X loss, quarter of loss lower in represent quarters loss not charge related to the of Aquestive for notes
XXXX, first first the the was $XX.X loss adjusted was increase Non-GAAP compared record first million quarter to XXX%. compared share GAAP an basic of first quarter and a of for to first XXXX, basic was increase quarter diluted XXXX. million $X.XX GAAP of $XX.X earnings in quarter per loss per quarter in EBITDA diluted share XX%. the in an in compared of and $X.XX in per the Non-GAAP adjusted of $X.XX the the first $X.XX share of to quarter
We today for please GAAP earlier results. our reconciliation non-GAAP press see a release issued to of
March balance of $XXX.X increased XX, cash XXXX, As to our million.
our During quarter, the we in notes. to million $XX debt term paid down related
senior with with repurchase million debt. portion a note a hygiene. million later February We notes provides corporate in proceeds more $XXX.X convertible our due also XXXX. us of financial of We XXXX our of offering matter a completed in management in maturity The flexibility the good used $XXX.X of to as maturity offering from convertible a the
adjusted approximately had intend costs, to first million purposes, X.Xx general of net debt issuance to deployment at net capital approximately expect the for of $XX note including Xx. year the strategy. we implementation at use proceeds, We to After quarter EBITDA end corporate of the which the we our ended and
We are strong financial pleased the quarter first with as progress performance, for year. making execute our we which reflects our the are we objectives
XXXX. financial are guidance We reaffirming our for
range net operating of in to expenses $XXX adjusted $XXX range $XXX the EBITDA the and expect $XXX product in of million. adjusted in $XXX of $XXX million million to million revenues million We range the to million,
deployment creating capital focused long-term strategy Our our value shareholders. for is on
Our financial capital our us execute allows strong position strategy. deployment to
and to approach we market Our transaction to disciplined in committed getting is a a done. we taking top development, business priority potentially conducive a are that believe is
our rapidly balance in to locked are We sheet. deleveraging
debt track to which repay put $XXX.X on approximately at year-end. debt million adjusted at in Xx XXXX, to We’re would net of us EBITDA
is strong to ability our a quickly to testament generation. delever cash Our
return the shareholders repurchase capital our XXXX, authorized to Board $XXX program. our a we to million. our share by In new ability for program strategically leveraging January Finally, have repurchase share
with key very our pleased as XXXX and We first financial and quarter against our strong to are priorities. start positively track performance strategic we
now to turn will over I Scott. it
